Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Research in Real-Life Ltd
With
Teva Branded Pharmaceutical Products R&D, Inc.
Age
16–70
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Aged 16-70 years
Current smokers - explicitly coded in patient records or captured in patient questionnaires
Evidence of asthma diagnosis and current therapy: ≥2 prescriptions for asthma at different points in time during the baseline year ± a diagnostic code for asthma
On-going asthma therapy: ≥2 prescription for ICS during the outcome period (i.e. ≥1 prescription in addition to IPD prescription)
≥2 years continuous data (i.e. ≥1 year of baseline plus ≥1 year of outcome data)
You may not be if
Patients will be excluded from the analysis if they have:
Any chronic respiratory disease other than asthma
Are prescribed:
Maintenance oral steroid therapy during the baseline year
Combination ICS/long-acting beta agonist (LABA) therapy during baseline year or at IPD
Multiple ICS prescriptions at IPD or immediately before .
Clareo Health | Qvar Therapy in Smoking Asthmatics
